These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22172876)

  • 1. Oxidative stress indices in rats under immunosuppression.
    Kedzierska K; Sporniak-Tutak K; Bober J; Safranow K; Olszewska M; Jakubowska K; Domański L; Gołembiewska E; Kwiatkowska E; Laszczyńska M; Dołegowska B; Ciechanowski K
    Transplant Proc; 2011 Dec; 43(10):3939-45. PubMed ID: 22172876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of mycophenolate mofetil against nephrotoxicity and hepatotoxicity induced by tacrolimus in Wistar rats.
    Ferjani H; El Arem A; Bouraoui A; Achour A; Abid S; Bacha H; Boussema-Ayed I
    J Physiol Biochem; 2016 Jun; 72(2):133-44. PubMed ID: 26746208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results.
    Kaczmarek I; Zaruba MM; Beiras-Fernandez A; Reimann R; Nickel T; Grinninger C; Sadoni S; Hagl C; Meiser B
    J Heart Lung Transplant; 2013 Mar; 32(3):277-84. PubMed ID: 23415313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
    Bunnapradist S; Daswani A; Takemoto SK
    Transplantation; 2003 Jul; 76(1):10-5. PubMed ID: 12865780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results.
    Guethoff S; Stroeh K; Grinninger C; Koenig MA; Kleinert EC; Rieger A; Mayr T; von Ziegler F; Reichart B; Hagl C; Schramm R; Kaczmarek I; Meiser BM
    J Heart Lung Transplant; 2015 May; 34(5):634-42. PubMed ID: 25701373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of mycophenolate mofetil on cardiotoxicity induced by tacrolimus in wistar rats.
    Ferjani H; Timoumi R; Amara I; Abid S; Achour A; Bacha H; Boussema-Ayed I
    Exp Biol Med (Maywood); 2017 Feb; 242(4):448-455. PubMed ID: 26582055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats.
    Selcoki Y; Uz E; Bayrak R; Sahin S; Kaya A; Uz B; Karanfil A; Ozkara A; Akcay A
    Toxicology; 2007 Sep; 239(1-2):53-9. PubMed ID: 17689165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Comparison of Parameters of Oxidative Stress in Native Rat Livers Between Different Immunosuppressive Regimens.
    Wilk A; Szypulska-Koziarska D; Kędzierska-Kapuza K; Sieńko J; Kolasa-Wołosiuk A; Ciechanowski K; Wiszniewska B
    Med Sci Monit; 2019 Nov; 25():8242-8247. PubMed ID: 31677379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of different immunosuppressants on chronic allograft nephropathy by affecting the transforming growth factor-beta and Smads signal pathways.
    Gao R; Lu Y; Xin YP; Zhang XH; Wang J; Li YP
    Transplant Proc; 2006 Sep; 38(7):2154-7. PubMed ID: 16980029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of tacrolimus and mycophenolate mofetil induces oxidative stress and genotoxicity in spleen and bone marrow of Wistar rats.
    Ferjani H; Draz H; Abid S; Achour A; Bacha H; Boussema-Ayed I
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Nov; 810():48-55. PubMed ID: 27776691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effect of epicatchin against oxidative stress and nephrotoxicity in rats induced by cyclosporine.
    Al-Malki AL; Moselhy SS
    Hum Exp Toxicol; 2011 Feb; 30(2):145-51. PubMed ID: 20488842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
    Transplantation; 2012 Jan; 93(1):73-81. PubMed ID: 22129761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
    Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
    Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus and mycophenolate mofetil associations: Induction of oxidative stress or antioxidant effect?
    Ferjani H; Achour A; Bacha H; Abid S
    Hum Exp Toxicol; 2015 Nov; 34(11):1119-32. PubMed ID: 25645822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
    Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful reversal of acute vascular rejection and cyclosporine-associated nephrotoxicity in renal allograft with combined sirolimus and mycophenolate mofetil as immunotherapy.
    Ołdakowska-Jedynak U; Paczek L; Mucha K; Foroncewicz B; Perkowska-Ptasińska A
    Transplant Proc; 2006; 38(1):66-8. PubMed ID: 16504666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy.
    Rogers CC; Hanaway M; Alloway RR; Alexander JW; Boardman RE; Trofe J; Gupta M; Merchen T; Buell JF; Cardi M; Roy-Chaudhury P; Succop P; Woodle ES
    Transplant Proc; 2005 Mar; 37(2):795-7. PubMed ID: 15848534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.